Fortive Announces Appointment of Gregory Moore to Its Board of Directors

Rhea-AI Summary

Fortive (NYSE: FTV) has appointed Gregory Moore, M.D., Ph.D. to its Board of Directors, effective February 26, 2025, expanding the board from nine to ten members. Dr. Moore will serve on both the Compensation Committee and Nominating and Governance Committee.

Moore brings over 20 years of healthcare experience and expertise in AI and digital transformation. He previously served as Corporate Vice President of Microsoft Health & Life Sciences (2019-2023) and Vice President and Founder of Google Cloud Healthcare & Life Sciences (2016-2019). Currently, he serves as a Senior Advisor to Gates Ventures and Associate Fellow at Stanford University's Center for Artificial Intelligence in Medicine and Imaging.

The appointment aligns with Fortive's focus on accelerating innovation velocity and AI-powered growth strategies. Moore, who holds a PhD from MIT and MD from Wayne State University, is board certified in Diagnostic Radiology, Neuroradiology, and Clinical Informatics.

Positive

• Board strengthened with AI and healthcare technology expertise
• Addition of experienced executive with Microsoft and Google leadership background
• Strategic alignment with company's AI-powered growth initiatives

Negative

• None.

EVERETT, Wash.--(BUSINESS WIRE)-- Fortive Corporation ("Fortive") (NYSE: FTV) today announced that its Board of Directors (the “Board”) has appointed Gregory Moore, M.D., Ph.D., as a director of Fortive, effective February 26, 2025, with the size of the Board expanded from nine to ten members. In addition, Dr. Moore was appointed to the Compensation Committee and Nominating and Governance Committee.

Shar Dubey, Chair of the Board, said, “We are excited to welcome Greg to the Board of Directors during this important time in Fortive’s evolution. Greg brings over 20 years of healthcare experience and a deep background in AI and digital transformation, as well as significant executive leadership and public board experience, that will be valuable as Fortive accelerates its innovation velocity and AI-powered growth strategies.”

Dr. Moore is an engineer and physician, board certified in Diagnostic Radiology, Neuroradiology and Clinical informatics. He most recently served as the Corporate Vice President of Microsoft Health & Life Sciences at Microsoft from 2019 to 2023. Prior to Microsoft, Dr. Moore served as the Vice President and Founder of Google Cloud Healthcare & Life Sciences at Google from 2016 to 2019. He currently serves as a Senior Advisor to Gates Ventures and as an Associate Fellow at Stanford University’s Center for Artificial Intelligence in Medicine and Imaging. Dr. Moore holds a PhD in Radiological Sciences from Massachusetts Institute of Technology, and MD from Wayne State University School of Medicine. Dr. Moore also serves as a member of the Board of Directors at DaVita Inc.

“Fortive’s clear sense of purpose and unwavering dedication to essential technologies that enhance safety and productivity in operating environments around the world truly resonate with me,” said Dr. Moore. “I am delighted to be joining the Board and look forward to working alongside my fellow directors and the executive team to oversee the execution of strategy and technology initiatives that expand access to innovation and drive meaningful impact, and to contribute to the creation of sustainable value for all stakeholders.”

James A. Lico, Fortive’s Chief Executive Officer, President and Director, stated, “Greg’s established accomplishments in revolutionizing healthcare with innovative technologies make him an ideal addition to the Fortive Board. We look forward to benefiting from his unique insights and passion for innovation.”

Olumide Soroye, current President and CEO of Fortive’s Intelligent Operating Solutions and Advanced Healthcare Solutions segments, stated, “Greg is a fantastic addition to our terrific board of directors. His deep passion for improving safety, productivity, and quality of care in healthcare operations around the world is perfectly aligned with our shared purpose at Fortive. Greg’s record of thought leadership and successful deployment of data science and AI-powered solutions will accelerate execution of our roadmap to unlock new value for our customers and shareholders.”

ABOUT FORTIVE

Fortive is a provider of essential technologies for connected workflow solutions across a range of attractive end-markets. Fortive’s strategic segments - Intelligent Operating Solutions, Advanced Healthcare Solutions, and Precision Technologies - include well-known brands with leading positions in their markets. The company’s businesses design, develop, service, manufacture, and market professional and engineered products, software, and services, building upon leading brand names, innovative technologies, and significant market positions. Fortive is headquartered in Everett, Washington and employs a team of more than 18,000 research and development, manufacturing, sales, distribution, service and administrative employees in more than 50 countries around the world. With a culture rooted in continuous improvement, the core of our company’s operating model is the Fortive Business System. For more information please visit: www.fortive.com.

FORWARD-LOOKING STATEMENTS

Statements in this release that are not strictly historical, including statements regarding the proposed separation, the future financial impact or anticipated benefits of the separation, the anticipated prospects and strategies of Fortive, or the industries in which Fortive will operate following the separation, future opportunities for Fortive, and any other statements identified by their use of words like “anticipate,” “expect,” “believe,” “outlook,” “guidance,” “target,” or “will” or other words of similar meaning, are “forward-looking statements” within the meaning of the United States federal securities laws. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things: deterioration of or instability in the economy, the markets we serve, geopolitical conditions and conflicts, international trade policies and the financial markets, security breaches or other disruptions of our information technology systems, supply chain constraints, our ability to adjust purchases and manufacturing capacity to reflect market conditions, reliance on sole sources of supply, changes in trade relations with other countries, contractions or lower growth rates and cyclicality of markets we serve, competition, changes in industry standards and governmental regulations, our ability to recruit and retain key employees, our ability to successfully identify, consummate, integrate and realize the anticipated value of appropriate acquisitions and successfully complete divestitures and other dispositions, our ability to develop and successfully market new products, software, and services and expand into new markets, the potential for improper conduct by our employees, agents or business partners, contingent liabilities relating to acquisitions and divestitures, impact of changes to tax laws, our compliance with applicable laws and regulations and changes in applicable laws and regulations, risks relating to international economic, geopolitical, including war and sanctions, legal, compliance and business factors, risks relating to potential impairment of goodwill and other intangible assets, currency exchange rates, tax audits and changes in our tax rate and income tax liabilities, the impact of our debt obligations on our operations, litigation and other contingent liabilities including intellectual property and environmental, health and safety matters, our ability to adequately protect our intellectual property rights, risks relating to product, service or software defects, product liability and recalls, risks relating to product manufacturing, our relationships with and the performance of our channel partners, commodity costs and surcharges, adverse effects of restructuring activities, our plans to separate into two independent, publicly-traded companies, risk related to tax treatment of our prior or pending separation, impact of our indemnification obligation to Vontier, impact of changes to U.S. GAAP, labor matters, and disruptions relating to man-made and natural disasters and climate change. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings, including our Annual Report on Form 10-K for the year ended December 31, 2024. These forward-looking statements speak only as of the date of this presentation, and Fortive does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250226339722/en/

Elena Rosman

Vice President, Investor Relations

Fortive Corporation

6920 Seaway Boulevard

Everett, WA 98203

Telephone: (425) 446-5000

Source: Fortive Corporation

FAQ

When will Gregory Moore join Fortive's (FTV) Board of Directors?

Gregory Moore will join Fortive's Board of Directors effective February 26, 2025.

What committees will Gregory Moore serve on at Fortive (FTV)?

Dr. Moore will serve on both the Compensation Committee and Nominating and Governance Committee.

What is Gregory Moore's healthcare and technology experience before joining Fortive (FTV)?

He served as Corporate VP of Microsoft Health & Life Sciences (2019-2023) and VP/Founder of Google Cloud Healthcare & Life Sciences (2016-2019).

How does Gregory Moore's appointment align with Fortive's (FTV) strategic goals?

His expertise in AI and digital transformation aligns with Fortive's focus on accelerating innovation velocity and AI-powered growth strategies.